Proarrhythmic Effects of Cancer Therapies

In the era of modern, targeted oncological treatment, physicians of all specialties face a challenge of optimal management of adverse effects. Arrhythmias directly related to anticancer drugs administration, although common, rarely lead to patients’ death (provided adequate monitoring) and often resolve soon after drugs discontinuation. Due to the lack of strict guidelines, the decision to discontinue drugs should only be made by a team of experienced oncologists and cardiologists.